Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 134

Results For "IRA"

1454 News Found

DiaCarta receives CE/IVD for its Covid-19 screening test
Biotech | September 10, 2021

DiaCarta receives CE/IVD for its Covid-19 screening test

This test can be run on commonly available qPCR cyclers, thereby, bypassing the need to perform expensive and time-consuming Next-Generation Sequencing


DCGI grants EUA to Truenat for conducting Nipah virus tests
Digitisation | September 09, 2021

DCGI grants EUA to Truenat for conducting Nipah virus tests

Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


Biocon settles suit with Celgene for generic Revlimid
Biotech | September 08, 2021

Biocon settles suit with Celgene for generic Revlimid

Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020


Metropolis Healthcare opens a new testing centre in Latur, Maharashtra
Healthcare | September 08, 2021

Metropolis Healthcare opens a new testing centre in Latur, Maharashtra

The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.


Indian Pharmaceutical Market grew by 17.7 per cent in August
News | September 07, 2021

Indian Pharmaceutical Market grew by 17.7 per cent in August

Ind-Ra expects IPM revenue to grow over 12% YoY in FY22


Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine
News | September 07, 2021

Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine

The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories


Sharp develops Plasmacluster tech that reduces airborne novel coronavirus
Drug Approval | September 07, 2021

Sharp develops Plasmacluster tech that reduces airborne novel coronavirus

Plasmacluster technology significantly inactivates SARS-CoV-2 contained in adherent saliva in an environment with 60% humidity where the physiological protective function is maintained


Max Ventilator forms partnership with US-based Amptron Medical
Drug Approval | September 07, 2021

Max Ventilator forms partnership with US-based Amptron Medical

Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.


Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19
Drug Approval | September 06, 2021

Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19

Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence